This case study analyzes CO₂ emissions for manufacturing a 10 kg batch of pharmaceuticals, comparing SeraNovo’s liquid formulation to SSD
Pharmaceutical companies are under increasing pressure to adopt sustainable manufacturing practices. This case study examines the carbon footprint of producing a 10 kg batch of pharmaceutical products, highlighting how SeraNovo’s innovative liquid formulation technology significantly reduces CO₂ emissions compared to traditional spray-dried dispersion (SDD) methods.
Key Sustainability Benefits
Conclusion
- SeraNovo's liquid formulation technology offers a sustainable, energy-efficient alternative to traditional manufacturing methods.
- Proprietary cosolvent technology enhances solubility performance.
- Significantly reduces the carbon emissions associated with pharmaceutical manufacturing.
- Simplifies processes while ensuring regulatory compliance and scalability.
